分组1 - Sight Sciences, Inc. reported a quarterly loss of $0.08 per share, better than the Zacks Consensus Estimate of a loss of $0.15, and improved from a loss of $0.23 per share a year ago, resulting in an earnings surprise of +44.83% [1] - The company achieved revenues of $20.39 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.34% and showing an increase from $19.07 million in the same quarter last year [2] - Sight Sciences has consistently exceeded consensus EPS estimates over the last four quarters, indicating strong performance in earnings expectations [2] 分组2 - The stock has underperformed, losing about 33.7% since the beginning of the year, compared to a decline of 0.4% in the S&P 500 [3] - The company's earnings outlook is crucial for investors, with current consensus EPS estimates at -$0.18 for the coming quarter and -$0.59 for the current fiscal year [7] - The Medical - Instruments industry, to which Sight Sciences belongs, is currently ranked in the top 32% of over 250 Zacks industries, suggesting a favorable industry outlook [8]
Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Beats Revenue Estimates